For Men suffering from prostate issues, we offer Non-Surgical prostate treatment. Prostate enlargement is one of the most common ailments among the male population aged >35. Symptoms include frequent bathroom breaks and incomplete bladder evacuation.
Intimacy engagements become an unspoken trigger of male anxiety and embarrassment, resulting in avoidance of the situation. Even after attempted treatments, it is common for the condition to deteriorate.
Consider UroLift. A prostate treatment available in Indore, performed by Dr. Vikas Singh of Kokilaben Dhirubhai Ambani Hospital, Indore. Never requires general anesthesia as it utilizes workplace anesthesia. Most patients perform the treatment and return to work the next day!
Urinary tract obstruction is a direct cause of the inflammatory enigma of the prostate, and UroLift is the best method of treatment, as it solves the problem by opening the obstruction without the removal of prostate tissue.
Dr. Vikas Singh is one of the first proUroLift advocates and now practices as a Urologist in Indore. His practice of transforming the condition of the male population continues, and the condition continues to drastically improve post treatment.
For patients living with prostate problems who have been reluctant to have surgery for fear of sexual side effects or are looking for a non-invasive, faster solution, UroLift could be just what you’ve been searching for.
UroLift is a medical device used to treat Benign Prostatic Hyperplasia (BPH). The FDA and CE have approved this device as a minimally invasive option to treat non-cancerous prostate growth. BPH affects men worldwide and is a growing concern as it can disrupt urination.
Instead of reshaping or removing prostate cells, UroLift uses small medical devices called UroLift implants to hold enlarged prostate lobes back. These implants create a clear opening to ensure urine can flow without any obstruction from prostate growth in the urethra.
UroLift implants are made of stainless steel and nitinol and are durable when used in the human body. Each implant is equipped with a small cap which anchors to the external prostate, a urethral end-piece which sits against the inner urethra, and a suture which holds together the protruding lobe. These UroLift end-pieces pull the lobe away from the urethra.
During a UroLift, doctors can place between 4 and 6 implants. The urethral gap is changed based on the anatomy and size of the prostate. Each implant takes a few seconds to position, and the procedure as a whole lasts from about 30 to 60 minutes.
There is anecdotal evidence to suggest that in a fraction of patients with Prostate Budding (BPH), once the implant is correctly sited and opens the urethra, the patient has an extremely distended bladder that is just above the pubic bone at a level that is normally above the top of the pubic bone, there is complete urinary obstruction, and no outflow is possible.
Based on results, patients subjected to the Urolift procedure, on average, report a significantly improved quality of life with the capability of bladder emptying, and the distention to a lower level, even with complete obstruction, is not a problem, as it is with limited lumen outflow. Reports also state that no loss of bladder compliance has been noted following the procedure, and the bladder is not distended beyond the level of the pubic bone, as is the case with complete obstruction.
It is also reported that the Urolift procedure has been in use in excess of 10 years, that it is reasonably safe, and that the long-term effects, based on relatively limited studies of less than 36 months in some cases, vary in not significantly reducing urinary frequency, and in some cases significantly improving it.
The implants are MRI-safe, meaning they won’t interrupt other medical procedures, are undetectable, and permanent. They must be placed once and never removed, and can be placed sub-dermally without being noticeable by either the patient or their partner.
This is the question that surprises almost every patient when they first hear about UroLift. Patients are often curious how positioning the enlarged lobes out of the way of the urethra can be done without cutting, burning, or tissue removal.
This can be answered quickly by considering that the lobes are mechanically compressing the urethra. This is the essence of the BPH mechanical problem. The solution for most BPH surgical procedures is to either remove or destroy the compressing tissue. During a TURP or a laser-based procedure, the inner tissue of the prostate is either resected or enucleated, and the outer tissue is vaporized or ablated.
Addressing the problem of compressive obstruction is a mechanistic function of the UroLift system. Lifting the enlarged lobes out of the way of the urethra is done by permanent implants. While the system itself is mechanistic, this procedure is done without cutting or removing tissue and without the application of burning or cutting tools.
Sometimes referred to as “lift and lock,” this technique is one of UroLift’s most notable advantages: its preservation of sexual and ejaculatory function. During UroLift, no thermal injury is sustained to the ejaculatory ducts or the bladder neck, meaning the anatomic structures involved in normal ejaculation are not affected. Trials have overwhelmingly demonstrated the preservation of ejaculatory function after UroLift in the majority of patients.
UroLift was made for men with moderate and severe Lower Urinary Tract Symptoms (LUTS) associated with BPH, specifically with an International Prostate Symptom Score (IPSS) above 12, Qmax flow rates of 12 to 15 ml/sec, and prostate sizes (within the 30 to 80 gram limit) that are optimal for UroLift.
UroLift is particularly suitable for those men with poor symptom control despite the use of both medications (combination therapy of Alpha blockers and 5-alpha-reductase inhibitors), preferring to treat the mechanical problem without taking medications for the rest of their life, as well as those men who are thinking of undergoing an operative procedure, and are looking for a less aggressive alternative to TURP and soft tissue laser enucleation.
This is the most important and most common reason for UroLift’s preferential breakout amongst the BPH range of therapies. Retrograde ejaculation (where the semen is ejaculated backwards and instead of out) affects from 50 up to 90 percent of patients post TURP, HoLEP, and ThuFLEP. Although retrograde ejaculation is not an adverse event, it is a permanent negative change to the patient’s sexual experience and renders them infertile.
Retrograde ejaculation is a source of distress for younger men, as sexual intimacy preserves ejaculatory function. Since the LIFT randomized control trial, almost 100% of participants maintain ejaculatory function after going through the UroLift procedure. The UroLift trial demonstrated that the UroLift procedure excels in supporting ejaculatory functions post-procedure.
Men’s participants are also able to retain their erectile functions after the procedure. The UroLift procedure is an ideal solution for men who are concerned about the outcomes of the procedure on their exit and entry functions.
No incision, no cuts, and no stitches is a sutureless method of the UroLift method as it harnessed the body’s natural anatomy — the bladder Sfingo. General anaesthetic is not an option for some participants, but for those who are concerned about the invasiveness of the UroLift procedure, the procedure is the most minimally invasive and effective solution.
UroLift is performed with the participant under local anaesthesia and sedation. At this level of sedation, the participant is comfortable, and the risks that are associated with general anaesthesia are no longer of concern. This also ensures that participants, who are not good candidates for general anaesthesia, are able to undergo UroLift.
UroLift is a technique meant for day procedures and is even designed for office settings. Most UroLift patients at Kokilaben Hospital are discharged to go home just a few hours after the procedure. A temporary catheter may be left in for 24 hours, but discomfort is seldom post-procedure, and normal activities are resumed well before the end of the week. Post-procedure care usually does not involve the use of a catheter for more than the immediate post-procedure time frame. For office-based work, we expect a return to work within 3-5 days.
A weak stream of urine is arguably the most common symptom of BPH. There is great difficulty initiating urination, and once started, the urine stream is thin and intermittent. It is common to see men anxiously standing at urinals while straining, pushing, and waiting, and watching urine supply a weak and frustrating stream. This symptom is a result of an enlarged prostate mechanically compressing the urethra. UroLift tackles this problem directly. UroLift retracts the obstructing lobes from the urethra and immediately opens the channel. The vast majority of patients experience a significant improvement in the strength of the stream from their very first urination after the procedure.
Nocturia is a word used to describe the sudden and repeated need to urinate while asleep. This symptom stands out in regard to the effects it has on sleep and the quality of life of those afflicted with BPH. Several patients with enlarged prostates report needing to wake up several times throughout the night, but some patients report needing to get up five to six times. Sleep deprivation caused by nocturia has effects throughout the day and results in irritability, fatigue, has a negative impact on focus and routine, and, for elderly patients, increases the chance of falls while using the bathroom at night.
Clinical studies show UroLift is successful in lessening nocturia, usually reducing the number of nightly calls from several to zero within weeks. Patients have reported less disruptive sleep while experiencing multiple UroLift benefits.
Many men suffering from BPH report having the same annoying, persistent feeling – the feeling of having to void soon after having finished an apparently complete urination. According to BPH experts, the feeling of incomplete voiding can be validated via the presence of an abnormal post-void residual volume (PVR) – the volume of urine remaining in the bladder after voiding.
UroLift can address high post-void residual volumes (PVR) by lessening bladder outlet obstruction (BOO) from the prostate once again. By reducing the resistance of the urethral channel, post-void residual volume decreases.
BPH-related bladder outlet obstruction can cause an overactive bladder. This is due to an obstruction of the prostate, which leads to detrusor overactivity of the bladder, which is the thickening and overactivity of the bladder wall. This condition causes a feeling of overactive bladder, where patients experience the feeling of an urgent need to urinate immediately, while in the presence of others or in a particular situation.
After UroLift alleviates the obstruction in the urethra, the secondary overactivity of the bladder usually lessens over the next few weeks/months, and the bladder adjusts to the reduced resistance to outflow. Clinical trials have noted that the urgency scores have improved significantly after UroLift. With most patients, a positive change in urinary control can be observed in the 4-8 week time frame.
The UroLift procedure requires a detailed assessment conducted by Dr. Vikas Singh. This ensures correct planning for the procedure. The following list outlines the preliminary UroLift procedure assessments:
At Kokilaben Hospital in Indore, a UroLift implant procedure involves the following steps:
Step 1- Preparation
A local analgesic is placed in the urine, and the patient is given IV sedation for relaxation and comfort. Similar to a cystoscopy, the patient is placed in the procedure chair/table, reclined.
Step 2- Instrument Introduction
The UroLift delivery device is a slim cystoscopy device, which is used to insert the UroLift implants. Dr. Vikas Singh observes the urethra and prostate lobes via a video monitor during this step.
Step 3- Implant
The UroLift delivery device is placed at the incision point on the prostatic lateral lobe. It’s designed to allow the capsular tab to puncture the lobe, with the suture subsequently retracting the lobe as lateral pressure is applied. The tab, which rests in the urethra, is locked to the lumen wall.
Step 4- Implant
The system is repeated. Systematically placing 4-6 implants across the lateral lobes opens the prostatic urethra fully. Dr. Vikas Singh can observe the urethral channel widening with each UroLift placed.
Cystoscopic evaluation of the urethra takes place at the end of the placement of the implants. The openings of the implants and the presence of bleeding are assessed as part of this process.
Regarding the end of the procedure, the implants’ delivery device is removed. While not the norm, some may receive a urinary catheter for the next 24 hours. After a 30–60 minute observation, the patients are usually free to leave and given a post-operative instruction booklet.
From start to finish, the UroLift procedure typically takes 30 to 60 minutes, including the cystoscopic assessment, the placement of the implants, and the final inspection. One of the benefits of the UroLift procedure over TURP and laser enucleation procedures is the relatively short procedure time and the fact that local anesthesia and sedation are the only forms of anesthesia used.
At Kokilaben Hospital, the types of anesthesia used for UroLift procedures include local anesthesia and sedation via an IV (most common, both relaxed and comfortable, as breathing is done independently), spinal anesthesia (complete numbness in the legs), and general anesthesia (full sleep, for patients with major anxiety). Dr. Vikas Singh and the anesthetic team will consider the patient’s medical history and preference to select the best option.
At Kokilaben Hospital, the majority of patients who undergo UroLift are discharged on the same day of the procedure. Below are the post-UroLift procedure descriptions of what happens during these first hours. Vital signs are taken in the recovery area while the patient rests for a short period. The patient is administered medication for mild urethral and post-voiding or urination discomfort and urgent needs. Once the patient meets the requirements of achieving urination (no catheter is placed), is discharged, and has recovered, the patient is fully alert and is taken home with full guard.
You’ll receive a clear guide explaining recommendations for fluid intake and activity, and a timeline for your first few days and notes on when and why to contact the clinic. Our suggested follow-up appointments are included. For the initial 1-2 days, please call the clinic with any questions that you may not wish to share with the surgeon.
The following have been reviewed thoroughly, and a clear comparison of UroLift and the most common BPH treatments is presented.
Factor | UroLift | Traditional TURP | HoLEP / ThuFLEP |
Prostate Tissue Removed | No – mechanical retraction only | Yes – resected chip by chip | Yes – complete enucleation |
Heat / Laser Energy Used | No – no thermal injury | Yes – electrical current | Yes – laser energy |
Ejaculatory Function | Preserved in >95% of patients | Lost in 50–90% (retrograde EJ) | Lost in 50–90% (retrograde EJ) |
Erectile Function | Preserved | Usually preserved | Usually preserved |
Blood Loss | Negligible | Moderate | Near zero |
TURP Syndrome Risk | None | Present (monopolar TURP) | None |
Anaesthesia | Local + sedation (most cases) | Spinal or general | Spinal or general |
Procedure Time | 30–60 minutes | 60–90 minutes | 60–120 minutes |
Hospital Stay | Same-day discharge | 2–3 days | 1–2 days |
Catheter Duration | 0–24 hours | 48–72 hours | 24–48 hours |
Recovery | 3–7 days | 2–4 weeks | 1–3 weeks |
Prostate Size Limit | Best for 30–80 grams | Up to ~80–100 grams | No size limit |
Long-term Durability | Good – 5-year data excellent; some may need re-treatment | Good – 10–15% re-treat at 10 years | Excellent – <2% re-treat at 10 years |
Reversible? | Yes – implants can be removed; future TURP/HoLEP still possible | No – tissue permanently removed | No – tissue permanently removed |
UroLift is the only BPH technique to gain symptom-specific relief without cutting, burning, or removing, even the slightest bit, of prostate tissue. Burn-free, resect-free, laser-free, morcellator-free or even scalpel-free, help is available. Prostate tissue remains intact. Prostate lobes that are causing obstruction are simply moved using the UroLift implants.
Measuring the position of the implant is the differentiating factor of UroLift, with the entire range of BPH surgical treatment alternatives, which sets UroLift apart.
There was no greater goal of the LIFT trial than to preserve sexual ejaculatory performance among UroLift patients, than the achievement of ejaculatory performance, motivation, and funding, than that of patenting. UroLift patients saw no loss of ejaculatory performance, in stark contrast to 50 to 90% of the patients who do not achieve ejaculatory performance.
UroLift provides this outcome to its patients. Especially those who are aged between 40 – 60 years, i.e., in their middle and older age, those who conduct themselves sexually and whose ejaculatory and erectile performance form the crux of the quality of intimate relationships, and of life, to be differentiated from the other surgical treatment alternatives that the alternatives have with urinary symptoms.
There are drugs that are classified as 5-alpha-reductase inhibitors (finasteride, dutasteride), which take between 6 and 12 months to begin to shrink the prostate. Some may never completely control symptoms. Other drugs classified as alpha-blockers only give partial symptom relief. UroLift, however, gives immediate and quantifiable relief regarding urinary obstruction at the very moment the implants are inserted.
A vast majority of patients report a significant improvement in urinary function, seen as a stronger urinary stream within 24 to 72 hours of the UroLift procedure. Nocturia, the need to wake up during the night to urinate, generally improves within 1 to 2 weeks, and many studies report improved urinary function and continual improvement for the first 2 to 4 weeks that are directly related to post-procedure irritability of the urethra.
There is no thermal energy applied, so the Urology Lift does not destroy tissue. Thus, the side effects of Urology Lift severely differ from those of a prostate surgery. This means no bleeding, which makes it require a transfusion. There is no TURP syndrome. For about 90% of patients. There is no unintended permanent retrograde ejaculation. The inconvenience post surgery and the more irritating symptoms: mild burning of the urethra. Urgent symptoms that require more frequent urination go away after about 2 weeks max and about 1 week min.
After a Urology Lift surgery, you will recover after a period measured in days as opposed to weeks. Most men are back to work in 1 week, and for the more remote work, desk work is resumed within 3 to 5 days. TURP surgery patients take 2 to 4 weeks for recovery, and patients who choose laser enucleation take 1 to 3 weeks. The most practical benefit of the surgery is the minimal recovery disruption to a man’s routine work and family responsibilities.
Compared to traditional TURP and even laser enucleation, with the exception of still developing techniques, UroLift provides a greater level of safety. Nevertheless, the risk of potential complications must be discussed. Dr. Viskas Singh will spend time at the pre-operative assessment and address this with you.
Urethral Irritation (Very Common - First 2 to 4 Weeks)
Post-operative irritation with a stinging or burning sensation whilst urinating is to be expected with troubling or frustrating inconveniences after UroLift. This irritation is secondary to the trauma to the urethra due to the delivery device and the new implants. This temporary irritation will typically subside within 2 to 4 weeks due to the urethra encapsulating the implants.
Frequent Need to Urinate (Very Common - First 2 to 4 Weeks)
Like any BPH surgery you will be experiencing an adjustment to your new urethra and bladder, and the need to urinate will become frequent with an urgent sense to urinate during this period. To help soothe your bladder during the first few weeks, calming medications may be prescribed. These will ultimately subside with time, and infractions to the urethra.
Blood in the Urine (Common - First 2 to 5 Days)
Having blood in your urine immediately after a UroLift procedure may seem alarming, but it should be considered a normal occurrence, and it is a normal byproduct of some of the complications of surgery. Several litres of water will aid in reinforcing the return of blood to the normal eosinophil, and it will also be a byproduct that will be extremely common after your surgery, but it is a normal occurrence that is to be expected.
Temporary Pain (Common - First Few Days)
Some mild pelvic pain or a feeling of lower urinary tract pressure is common within the first two to three days of the procedure. These symptoms can be controlled with over-the-counter pain relief like paracetamol or mild anti-inflammatory medications, and typically become resolved within three to five days.
Retrograde Ejaculation (Uncommon - Less than 5%)
Unlike the procedure known as TURP or laser enucleation (where retrograde ejaculation occurs in 50% to as much as 90% of cases), clinical studies typically demonstrate that UroLift exhibits retrograde ejaculation in less than 5% of cases. This makes UroLift the most ejaculation-preserving BPH-supported surgical procedure currently. This is one of the most significant clinical advantages to UroLift in sexually active men.
Urinary Tract Infection (Uncommon - 3 to 5%)
Anytime a surgical procedure of a urological nature has taken place (in this case, a UroLift procedure), there is the possibility of a post-procedural urinary tract infection. To reduce this, a dosage of prophylactic antibiotics is taken both before and after the procedure. UTI cases are treated promptly with antibiotics.
Acute Urinary Retention Requiring Catheter (Uncommon - 5%)
Urethral swelling can lead to temporary post-procedural urinary retention that requires catheter drainage.
UroLift Implant Failure (Rare - Less than 1%)
Rarely, one of the UroLift implants can migrate from its original position or be expelled partially into the urethra. If symptoms are present, the implants can be cystoscopically removed. The remaining implants will continue to function properly.
In clinical studies, persistent results were seen in many patients, with only 15% needing re-treatment at the 5-year follow-up. 85% were symptom-free without the need for any other prostate BPH intervention. However, those with symptom recurrence, resulting from prostate regrowth, are presented with repeat UroLift, TURP, or laser procedure options. Importantly, UroLift does not pose subsequent procedural challenges.
UroLift functions optimally in a range of 30 to 80 gram prostate volume, without an obstructing median lobe. For especially enlarged prostates with a sizable median lobe, other options such as HoLEP, ThuFLEP, or TURP procedures will likely achieve better results. Dr. Vikas Singh will evaluate your particular case and will honestly disclose whether your case is more favorable for UroLift results or for other BPH procedures.
The results of UroLift are long-term, and patients mostly achieve satisfactory results for years. Participants of the clinical trial who reached the five-year follow-up and hadn’t needed subsequent interventions for BPH were in the bracket of 85%. UroLift devices are permanent. While UroLift’s results are permanent, if patients have worsening of symptoms from prostate regrowth, other procedures such as TURP and laser enucleation can be conducted, as UroLift does not impact the prostate’s structure.
Preservation of ejaculatory function after UroLift is at 95%, which means in most cases the treatment does not impair the ability to ejaculate. TURP and laser enucleation lead to retrograde ejaculation in 50% to 90% of procedures. UroLift is the best option for men who want to maintain their fertility and men who want to maintain their ability to ejaculate.
UroLift has been shown to be most effective for prostate sizes that are less than 80 grams. Prostates that are between 80 and 100 grams that contain an obstructing median lobe are better suited for procedures like the Holmium Laser Enucleation of the Prostate (HoLEP) or the Thulium Laser Enucleation of the Prostate (ThuFLEP). Before recommending a specific procedure, Dr. Vikas Singh will evaluate the volume and anatomy of the prostate.
After 24-72 hours of the UroLift procedure, most patients see a shift in the strength of their urinary stream. Overall, the majority of patients will see the complete relief of their urinary symptoms in the 2-4 week postoperative period. Typically, irritative symptoms of urgency and frequency will improve within the 2-4 week postoperative period. Nocturia is expected to improve significantly in the first 1-2 weeks.
UroLift maintains one of the most friendly procedures for patients with blood thinners. Because the tissue that is being displaced does not remain cut or cauterized, blood is lost in negligible amounts. Thus, anticoagulants can be continued throughout the entire UroLift procedure. Dr. Vikas Singh will provide specific advice for the medications at hand, and provide their personalized approach for perioperative management.
If UroLift does not help your symptoms and they return a few years after the procedure, there are additional treatment options available to you. UroLift does not destroy or remove prostate tissue, so there is also a large variety of TURP, HoLEP, and ThuFLEP that you could safely undergo. Furthermore, cystoscopic removal of UroLift implants can be performed if needed, well prior to other procedures. UroLift is a reversible procedure and thus does not severely limit the options available to you in the future. It is a safer alternative to some of the more invasive tissue-destructive procedures.
Both UroLift and Rezum are both minimally invasive, BPH (Benign Prostatic Hyperplasia) outpatient procedures. Rezum, however, uses steam to destroy prostate (prostatic) tissue, while UroLift does not use tissue destruction and relies on water vapour therapy. Rezum creates a temporary gap away and provides a recovery time of approximately 2 to 4 weeks, for the destroyed tissue to be reabsorbed. Rezum and UroLift differ in the rates of retrograde ejaculation, with Rezum being higher at around 10-15%. UroLift also has its strengths in order to manage median lobes, unlike Rezum. During the consultation, Dr. Vikas Singh will clarify which procedure is the most ideal.
UroLift does not treat or is not a procedure for prostate cancer, as it solely treats Benign Prostatic Hyperplasia (BPH). Dr. Vikas Singh makes a decision regarding prostate cancer at the time of consultation. Prostate cancer cannot be ruled out for the patient, as there are procedures for which UroLift is not permitted.
The UroLift procedure is done with local anaesthesia and sedation, and because of this, the majority of patients experienced hardly any pain during the procedure. For a few days afterward, you may experience some minor burning or stinging in your urethra when you urinate. This is better with pain relief. UroLift patients, in general, have mild to manageable pain and much less than what they anticipated before the procedure. This pain is also much less than the pain they experienced after some other procedures they had undergone.
24/7 Services Available
Copyright © 2026 Urology Center | All Rights Reserved
Design and Developed by Namastetu Technologies Pvt.Ltd
